US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist

5.650
+0.190+3.48%

Close Oct 18 16:00 ET

5.600
-0.050-0.88%

Post 20:01 ET

478.13MMarket Cap-2181P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

28.78%-34.16M

12.25%-43.08M

-22.25%-149.55M

-23.68%-40.68M

59.52%-11.81M

-79.24%-47.96M

-46.52%-49.1M

-57.08%-122.33M

-17.29%-32.89M

-36.62%-29.18M

Net income from continuing operations

7.74%-49.81M

6.23%-48.74M

-27.12%-200.07M

-17.69%-48.35M

-1.26%-45.76M

-31.84%-53.98M

-72.30%-51.98M

-30.81%-157.39M

-31.11%-41.09M

-98.65%-45.19M

Depreciation and amortization

24.68%1.67M

44.81%1.63M

94.54%5.46M

64.00%1.52M

105.58%1.47M

106.33%1.34M

119.26%1.13M

82.67%2.8M

95.97%925K

74.03%717K

Other non cash items

-94.90%120K

89.04%1.69M

173.73%6.63M

547.91%2.46M

-79.87%923K

636.76%2.35M

175.89%894K

-93.13%2.42M

14.49%-549K

2,184.55%4.59M

Change In working capital

292.73%5.75M

-22.08%-4.04M

111.25%17.7M

-168.22%-2.22M

434.08%26.22M

-138.12%-2.98M

56.49%-3.31M

387.77%8.38M

9,670.59%3.25M

426.61%4.91M

-Change in receivables

208.09%2.69M

-88.03%168K

-482.21%-5.89M

-3,243.37%-2.78M

---2.04M

---2.49M

--1.4M

---1.01M

---83K

----

-Change in prepaid assets

-992.28%-4.27M

71.44%-672K

85.10%-1.41M

1,836.76%1.18M

88.99%-713K

111.85%479K

-304.79%-2.35M

-25.35%-9.44M

96.35%-68K

-17.54%-6.47M

-Change in payables and accrued expense

313.49%7.11M

-771.55%-6.96M

101.59%3.68M

-64.42%1.27M

125.13%1.49M

-86.12%1.72M

90.31%-798K

-85.75%1.83M

-58.42%3.58M

-231.05%-5.91M

-Change in other current liabilities

55.60%-1.2M

21.10%-1.23M

-139.79%-7.22M

-1,017.65%-1.9M

40.99%-1.06M

-413.90%-2.7M

-199.04%-1.56M

63.24%-3.01M

97.49%-170K

-255.75%-1.79M

-Change in other working capital

--1.43M

--4.65M

42.61%28.54M

--2K

----

--20.01M

--0

----

Cash from discontinued investing activities

Operating cash flow

28.78%-34.16M

12.25%-43.08M

-22.25%-149.55M

-23.68%-40.68M

59.52%-11.81M

-79.24%-47.96M

-46.52%-49.1M

-57.08%-122.33M

-17.29%-32.89M

-36.62%-29.18M

Investing cash flow

Cash flow from continuing investing activities

-8.71%30.15M

-370.48%-41.63M

117.76%27.69M

94.72%-8.89M

78.68%-11.83M

324.38%33.03M

-74.39%15.39M

34.77%-155.96M

-195.36%-168.31M

73.85%-55.52M

Net PPE purchase and sale

63.19%-980K

87.17%-433K

29.84%-9.28M

56.02%-2.19M

59.76%-1.06M

2.10%-2.66M

-16.06%-3.38M

-203.56%-13.23M

-406.42%-4.97M

-163.17%-2.64M

Net investment purchase and sale

-12.77%31.13M

-319.53%-41.2M

125.91%36.97M

95.89%-6.71M

79.63%-10.77M

239.84%35.69M

-70.21%18.77M

39.20%-142.72M

-191.67%-163.35M

74.98%-52.88M

Cash from discontinued investing activities

Investing cash flow

-8.71%30.15M

-370.48%-41.63M

117.76%27.69M

94.72%-8.89M

78.68%-11.83M

324.38%33.03M

-74.39%15.39M

34.77%-155.96M

-195.36%-168.31M

73.85%-55.52M

Financing cash flow

Cash flow from continuing financing activities

5.27%1.3M

1,015.51%22.73M

-35.38%212.58M

347.96%177.38M

-88.93%31.92M

177.08%1.23M

303.56%2.04M

-12.76%328.96M

3,135.13%39.6M

33,365.05%288.41M

Net common stock issuance

21.54%-51K

1,031.56%22.48M

-35.54%210.46M

358.04%176.76M

-88.96%31.78M

---65K

--1.99M

14.47%326.5M

--38.59M

--287.91M

Net preferred stock issuance

----

--0

----

--0

----

Proceeds from stock option exercised by employees

5.27%1.3M

159.48%301K

-20.50%2.58M

-14.25%1.02M

-80.78%213K

177.08%1.23M

-77.03%116K

85.80%3.24M

-2.95%1.19M

--1.11M

Net other financing activities

----

21.54%-51K

41.51%-458K

-120.79%-393K

----

---65K

78.43%-783K

-9,000.00%-178K

----

Cash from discontinued financing activities

Financing cash flow

5.27%1.3M

1,015.51%22.73M

-35.38%212.58M

347.96%177.38M

-88.93%31.92M

177.08%1.23M

303.56%2.04M

-12.76%328.96M

3,135.13%39.6M

33,365.05%288.41M

Net cash flow

Beginning cash position

68.20%148.97M

75.45%210.95M

72.83%120.24M

-70.50%83.14M

-4.17%74.87M

-8.37%88.57M

72.83%120.24M

635.69%69.57M

83.77%281.84M

-79.86%78.13M

Current changes in cash

80.22%-2.71M

-95.73%-61.98M

79.04%90.72M

179.09%127.81M

-95.94%8.28M

26.05%-13.7M

-216.89%-31.67M

-15.71%50.67M

-92.84%-161.61M

186.86%203.72M

End cash Position

95.37%146.26M

68.20%148.97M

75.45%210.95M

-70.50%83.14M

-4.17%74.87M

-8.37%88.57M

72.83%120.24M

83.77%281.84M

Free cash flow

30.59%-35.14M

17.07%-43.52M

-17.16%-158.83M

-13.22%-42.87M

59.54%-12.87M

-71.74%-50.62M

-44.09%-52.47M

-64.84%-135.56M

-30.44%-37.86M

-42.29%-31.81M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	28.78%-34.16M	12.25%-43.08M	-22.25%-149.55M	-23.68%-40.68M	59.52%-11.81M	-79.24%-47.96M	-46.52%-49.1M	-57.08%-122.33M	-17.29%-32.89M	-36.62%-29.18M
Net income from continuing operations	7.74%-49.81M	6.23%-48.74M	-27.12%-200.07M	-17.69%-48.35M	-1.26%-45.76M	-31.84%-53.98M	-72.30%-51.98M	-30.81%-157.39M	-31.11%-41.09M	-98.65%-45.19M
Depreciation and amortization	24.68%1.67M	44.81%1.63M	94.54%5.46M	64.00%1.52M	105.58%1.47M	106.33%1.34M	119.26%1.13M	82.67%2.8M	95.97%925K	74.03%717K
Other non cash items	-94.90%120K	89.04%1.69M	173.73%6.63M	547.91%2.46M	-79.87%923K	636.76%2.35M	175.89%894K	-93.13%2.42M	14.49%-549K	2,184.55%4.59M
Change In working capital	292.73%5.75M	-22.08%-4.04M	111.25%17.7M	-168.22%-2.22M	434.08%26.22M	-138.12%-2.98M	56.49%-3.31M	387.77%8.38M	9,670.59%3.25M	426.61%4.91M
-Change in receivables	208.09%2.69M	-88.03%168K	-482.21%-5.89M	-3,243.37%-2.78M	---2.04M	---2.49M	--1.4M	---1.01M	---83K	----
-Change in prepaid assets	-992.28%-4.27M	71.44%-672K	85.10%-1.41M	1,836.76%1.18M	88.99%-713K	111.85%479K	-304.79%-2.35M	-25.35%-9.44M	96.35%-68K	-17.54%-6.47M
-Change in payables and accrued expense	313.49%7.11M	-771.55%-6.96M	101.59%3.68M	-64.42%1.27M	125.13%1.49M	-86.12%1.72M	90.31%-798K	-85.75%1.83M	-58.42%3.58M	-231.05%-5.91M
-Change in other current liabilities	55.60%-1.2M	21.10%-1.23M	-139.79%-7.22M	-1,017.65%-1.9M	40.99%-1.06M	-413.90%-2.7M	-199.04%-1.56M	63.24%-3.01M	97.49%-170K	-255.75%-1.79M
-Change in other working capital	--1.43M	--4.65M	42.61%28.54M	--2K	----	----	----	--20.01M	--0	----
Cash from discontinued investing activities
Operating cash flow	28.78%-34.16M	12.25%-43.08M	-22.25%-149.55M	-23.68%-40.68M	59.52%-11.81M	-79.24%-47.96M	-46.52%-49.1M	-57.08%-122.33M	-17.29%-32.89M	-36.62%-29.18M
Investing cash flow
Cash flow from continuing investing activities	-8.71%30.15M	-370.48%-41.63M	117.76%27.69M	94.72%-8.89M	78.68%-11.83M	324.38%33.03M	-74.39%15.39M	34.77%-155.96M	-195.36%-168.31M	73.85%-55.52M
Net PPE purchase and sale	63.19%-980K	87.17%-433K	29.84%-9.28M	56.02%-2.19M	59.76%-1.06M	2.10%-2.66M	-16.06%-3.38M	-203.56%-13.23M	-406.42%-4.97M	-163.17%-2.64M
Net investment purchase and sale	-12.77%31.13M	-319.53%-41.2M	125.91%36.97M	95.89%-6.71M	79.63%-10.77M	239.84%35.69M	-70.21%18.77M	39.20%-142.72M	-191.67%-163.35M	74.98%-52.88M
Cash from discontinued investing activities
Investing cash flow	-8.71%30.15M	-370.48%-41.63M	117.76%27.69M	94.72%-8.89M	78.68%-11.83M	324.38%33.03M	-74.39%15.39M	34.77%-155.96M	-195.36%-168.31M	73.85%-55.52M
Financing cash flow
Cash flow from continuing financing activities	5.27%1.3M	1,015.51%22.73M	-35.38%212.58M	347.96%177.38M	-88.93%31.92M	177.08%1.23M	303.56%2.04M	-12.76%328.96M	3,135.13%39.6M	33,365.05%288.41M
Net common stock issuance	21.54%-51K	1,031.56%22.48M	-35.54%210.46M	358.04%176.76M	-88.96%31.78M	---65K	--1.99M	14.47%326.5M	--38.59M	--287.91M
Net preferred stock issuance	----	----	--0	----	----	----	----	--0	----	----
Proceeds from stock option exercised by employees	5.27%1.3M	159.48%301K	-20.50%2.58M	-14.25%1.02M	-80.78%213K	177.08%1.23M	-77.03%116K	85.80%3.24M	-2.95%1.19M	--1.11M
Net other financing activities	----	21.54%-51K	41.51%-458K	-120.79%-393K	----	----	---65K	78.43%-783K	-9,000.00%-178K	----
Cash from discontinued financing activities
Financing cash flow	5.27%1.3M	1,015.51%22.73M	-35.38%212.58M	347.96%177.38M	-88.93%31.92M	177.08%1.23M	303.56%2.04M	-12.76%328.96M	3,135.13%39.6M	33,365.05%288.41M
Net cash flow
Beginning cash position	68.20%148.97M	75.45%210.95M	72.83%120.24M	-70.50%83.14M	-4.17%74.87M	-8.37%88.57M	72.83%120.24M	635.69%69.57M	83.77%281.84M	-79.86%78.13M
Current changes in cash	80.22%-2.71M	-95.73%-61.98M	79.04%90.72M	179.09%127.81M	-95.94%8.28M	26.05%-13.7M	-216.89%-31.67M	-15.71%50.67M	-92.84%-161.61M	186.86%203.72M
End cash Position	95.37%146.26M	68.20%148.97M	75.45%210.95M	75.45%210.95M	-70.50%83.14M	-4.17%74.87M	-8.37%88.57M	72.83%120.24M	72.83%120.24M	83.77%281.84M
Free cash flow	30.59%-35.14M	17.07%-43.52M	-17.16%-158.83M	-13.22%-42.87M	59.54%-12.87M	-71.74%-50.62M	-44.09%-52.47M	-64.84%-135.56M	-30.44%-37.86M	-42.29%-31.81M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data